Literature DB >> 7065722

Does rheumatoid arthritis have a clinicopathological spectrum similar to that of leprosy?

G S Panayi.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 7065722      PMCID： PMC1000875          DOI： 10.1136/ard.41.1.102

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

Review 1.  The immunopathology of joint inflammation in rheumatoid arthritis.

Authors:  N J Zvaifler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

2.  Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy.

Authors:  B Myrvang; T Godal; D S Ridley; S S Fröland; Y K Song
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

3.  The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases.

Authors:  D A Gordon; J L Stein; I Broder
Journal:  Am J Med       Date:  1973-04       Impact factor: 4.965

4.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep
  4 in total
  9 in total

1.  Rheumatoid vasculitis.

Authors:  D G Scott; P A Bacon
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

2.  Clinical and laboratory studies of arthritis in leprosy.

Authors:  S L Atkin; A el-Ghobarey; M Kamel; J P Owen; W C Dick
Journal:  BMJ       Date:  1989-05-27

3.  Studies of the effect of D-penicillamine and sodium aurothiomalate therapy on superoxide anion production by monocytes from patients with rheumatoid arthritis: evidence for in vivo stimulation of monocytes.

Authors:  N P Hurst; A L Bell; G Nuki
Journal:  Ann Rheum Dis       Date:  1986-01       Impact factor: 19.103

Review 4.  The immunopathobiology of syphilis: the manifestations and course of syphilis are determined by the level of delayed-type hypersensitivity.

Authors:  J Andrew Carlson; Ganary Dabiri; Bernard Cribier; Stewart Sell
Journal:  Am J Dermatopathol       Date:  2011-07       Impact factor: 1.533

5.  Serological profile of rheumatoid arthritis in west Africa.

Authors:  A O Adebajo; P J Charles; B L Hazleman; R N Maini
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

6.  Prediction of progressive joint damage in patients with rheumatoid arthritis receiving gold or D-penicillamine therapy.

Authors:  P T Dawes; P D Fowler; R Jackson; M Collins; M F Shadforth; R Stone; D L Scott
Journal:  Ann Rheum Dis       Date:  1986-11       Impact factor: 19.103

7.  Interleukin-2 reverses deficient cell-mediated immune responses in rheumatoid arthritis.

Authors:  P Emery; G S Panayi; A M Nouri
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

8.  The rheumatic manifestations of leprosy.

Authors:  S O Paira; S Roverano
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980

9.  Immunogenetic heterogeneity of rheumatoid arthritis.

Authors:  M L Westedt; F C Breedveld; G M Schreuder; J D'Amaro; A Cats; R R de Vries
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.